AMR Alliance Follows Up Global Industry Standard With Responsible Manufacturing Certification
BSI Certification Is Open To Any Manufacturer, For Any Drug
Executive Summary
A new voluntary certification from the AMR Industry Alliance and the British Standards Institution will assess pharmaceutical firms’ responsibility and sustainability when it comes to manufacturing antibiotic drugs, in an attempt to control the spread of antimicrobial resistance.
You may also be interested in...
New Pricing Policies Needed To Curb AMR Impact, States Industry Alliance Report
The AMR Industry Alliance has put forward six different policy proposals which it says could minimize the global impact of antimicrobial resistance.
BioFactura Completes Phase I For Late-To-Market Stelara Biosimilar
BioFactura has completed a successful Phase I trial of its Stelara (ustekinumab) biosimilar BFI-751, which is expected to file in developed markets in 2026.
Generics Industry Preps For Potential Entry Of Ukraine Into EU
Generics industry trade group Medicines for Europe has met with Ukrainian government officials to discuss how to plan for any future integration process.